Barkhof F - Search Results

1

Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis.

Rocca MA, Preziosa P, Barkhof F, Brownlee W, Calabrese M, De Stefano N, Granziera C, Ropele S, Toosy AT, Vidal-Jordana À, Di Filippo M, Filippi M. Rocca MA, et al. Among authors: barkhof f. Lancet Reg Health Eur. 2024 Aug 22;44:100978. doi: 10.1016/j.lanepe.2024.100978. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39444702 Free PMC article. Review.

2

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study.

Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH. Filippi M, et al. Among authors: barkhof f. Neurology. 1995 Feb;45(2):255-60. doi: 10.1212/wnl.45.2.255. Neurology. 1995. PMID: 7854522 Clinical Trial.

3

Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis.

Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH. Filippi M, et al. Among authors: barkhof f. Brain. 1995 Dec;118 ( Pt 6):1601-12. doi: 10.1093/brain/118.6.1601. Brain. 1995. PMID: 8595489 Review.

4

Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials.

Barkhof F, Filippi M, Miller DH, Tofts P, Kappos L, Thompson AJ. Barkhof F, et al. J Neurol. 1997 Feb;244(2):76-84. doi: 10.1007/s004150050053. J Neurol. 1997. PMID: 9120500

5

Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials.

Filippi M, van Waesberghe JH, Horsfield MA, Bressi S, Gasperini C, Yousry TA, Gawne-Cain ML, Morrissey SP, Rocca MA, Barkhof F, Lycklama à Nijeholt GJ, Bastianello S, Miller DH. Filippi M, et al. Among authors: barkhof f. Neurology. 1997 Aug;49(2):371-7. doi: 10.1212/wnl.49.2.371. Neurology. 1997. PMID: 9270564

6

Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis.

Filippi M, Barkhof F, Bressi S, Yousry TA, Miller DH. Filippi M, et al. Among authors: barkhof f. Mult Scler. 1997 Aug;3(4):226-30. doi: 10.1177/135245859700300402. Mult Scler. 1997. PMID: 9372504 Clinical Trial.

7

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Adèr HJ, Losseff N, Valk J. Barkhof F, et al. Brain. 1997 Nov;120 ( Pt 11):2059-69. doi: 10.1093/brain/120.11.2059. Brain. 1997. PMID: 9397021 Review.

8

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.

Barkhof F, Filippi M, van Waesberghe JH, Molyneux P, Rovaris M, Lycklama à Nijeholt G, Tubridy N, Miller DH, Yousry TA, Radue EW, Adèr HJ. Barkhof F, et al. Neurology. 1997 Dec;49(6):1682-8. doi: 10.1212/wnl.49.6.1682. Neurology. 1997. PMID: 9409366

9

Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis.

Filippi M, Gawne-Cain ML, Gasperini C, vanWaesberghe JH, Grimaud J, Barkhof F, Sormani MP, Miller DH. Filippi M, et al. Among authors: barkhof f. Neurology. 1998 Jan;50(1):238-44. doi: 10.1212/wnl.50.1.238. Neurology. 1998. PMID: 9443486

10

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

Molyneux PD, Filippi M, Barkhof F, Gasperini C, Yousry TA, Truyen L, Lai HM, Rocca MA, Moseley IF, Miller DH. Molyneux PD, et al. Among authors: barkhof f. Ann Neurol. 1998 Mar;43(3):332-9. doi: 10.1002/ana.410430311. Ann Neurol. 1998. PMID: 9506550 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,515 results

Search Page

Filters